|
Volumn 7, Issue 5, 2011, Pages 1512-1522
|
Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
NANOPARTICLE;
TNFRSF10A PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;
ARTICLE;
CELL ADHESION;
CELL CYCLE;
CELL LINE;
CELL SURVIVAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
CONFOCAL MICROSCOPY;
DOSE RESPONSE;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG POTENTIATION;
ENDOCYTOSIS;
HUMAN;
METABOLISM;
METHODOLOGY;
MICELLE;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CELL ADHESION;
CELL CYCLE;
CELL LINE;
CELL LINE, TUMOR;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG DELIVERY SYSTEMS;
DRUG SYNERGISM;
ENDOCYTOSIS;
HUMANS;
MICELLES;
MICROSCOPY, CONFOCAL;
MOLECULAR STRUCTURE;
NANOPARTICLES;
RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
|
EID: 79954456772
PISSN: 1742206X
EISSN: 17422051
Source Type: Journal
DOI: 10.1039/c0mb00266f Document Type: Article |
Times cited : (31)
|
References (47)
|